A detailed history of Citigroup Inc transactions in Opko Health, Inc. stock. As of the latest transaction made, Citigroup Inc holds 130,918 shares of OPK stock, worth $198,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,918
Previous 1,523,241 91.41%
Holding current value
$198,995
Previous $1.83 Million 91.08%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$1.21 - $1.42 $1.68 Million - $1.98 Million
-1,392,323 Reduced 91.41%
130,918 $163,000
Q1 2024

May 10, 2024

SELL
$0.87 - $1.57 $22,916 - $41,355
-26,341 Reduced 1.7%
1,523,241 $1.83 Million
Q4 2023

Feb 09, 2024

BUY
$1.23 - $1.63 $80,963 - $107,293
65,824 Added 4.44%
1,549,582 $2.34 Million
Q3 2023

Nov 09, 2023

SELL
$1.5 - $2.17 $198,877 - $287,709
-132,585 Reduced 8.2%
1,483,758 $2.37 Million
Q2 2023

Aug 10, 2023

BUY
$1.37 - $2.17 $160,832 - $254,749
117,396 Added 7.83%
1,616,343 $3.51 Million
Q1 2023

May 11, 2023

SELL
$1.06 - $1.61 $671,548 - $1.02 Million
-633,536 Reduced 29.71%
1,498,947 $2.19 Million
Q4 2022

Feb 09, 2023

SELL
$1.05 - $2.01 $10,404 - $19,917
-9,909 Reduced 0.46%
2,132,483 $2.67 Million
Q3 2022

Nov 10, 2022

SELL
$1.81 - $2.81 $45,650 - $70,871
-25,221 Reduced 1.16%
2,142,392 $4.05 Million
Q2 2022

Aug 10, 2022

BUY
$2.33 - $3.61 $4.4 Million - $6.81 Million
1,887,666 Added 674.29%
2,167,613 $5.48 Million
Q1 2022

May 12, 2022

SELL
$2.87 - $4.93 $1.34 Million - $2.3 Million
-465,786 Reduced 62.46%
279,947 $963,000
Q4 2021

Feb 10, 2022

BUY
$3.52 - $5.15 $465,495 - $681,051
132,243 Added 21.56%
745,733 $3.59 Million
Q3 2021

Nov 10, 2021

BUY
$3.44 - $4.24 $2.11 Million - $2.6 Million
613,490 New
613,490 $2.24 Million

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.17B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.